AIM
ARA

Acrospire Investment Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Acrospire Investment Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-48
Closed -$1K – 1762
2017
Q2 		$1K Sell
48
-993
-95% -$17.3K ﹤0.01% 2121
2017
Q1 		$18K Sell
1,041
-6,944
-87% -$139K 0.01% 1677
2016
Q4 		$170K Sell
7,985
-3,364
-30% -$69K 0.07% 485
2016
Q3 		$207K Buy
11,349
+6,849
+152% +$154K 0.14% 144
2016
Q2 		$130K Buy
+4,500
New +$125K 0.1% 267

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acrospire Investment Management's ARA Position: Q3 2017 in Review

Acrospire Investment Management sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2017, closing a stake of 48 shares — an estimated $1K sold.

Acrospire Investment Management first reported a position in ARA in Q2 2016 and held it in 5 quarters. The position peaked at $207K in Q3 2016. 61 funds tracked by Wall St. Rank hold ARA as of Q3 2017.

  • Acrospire Investment Management reported no remaining American Renal Associates Holdings, Inc position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 48 American Renal Associates Holdings, Inc shares in Q3 2017, an estimated $1K.
  • Acrospire Investment Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's American Renal Associates Holdings, Inc position peaked at $207K in Q3 2016.
  • 61 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.